Mizuho Therapeutics Conference - ANAVEX

Skip to content

ANAVEX

HOME
ABOUT US
OUR TEAM
NEWS
INVESTORS
JOIN US

Search: Search

HOME
ABOUT US
OUR TEAM
NEWS
INVESTORS
JOIN US

Event:	Mizuho Therapeutics Conference
Date/Time:	Wednesday, September 21, 2016
Location:	Langham Hotel, Boston, MA

Post navigation

PreviousPrevious post:Anavex Reports Fiscal Third Quarter 2016 Financial Results NextNext post:Anavex to Participate in Mizuho Therapeutics Conference

Related Posts

Anavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study Updates
December 16, 2019

Anavex Life Sciences to Announce Fiscal 2019 Year End Financial Results on Monday December 16, 2019
December 10, 2019

Anavex Life Sciences Presents ANAVEX®2-73 (blarcamesine) Data at 12th Clinical Trials on Alzheimer’s Disease (CTAD) 2019 Conference
December 4, 2019

Anavex Life Sciences Receives Rare Pediatric Disease Designation from FDA for ANAVEX®2-73 (blarcamesine) for the Treatment of Rett Syndrome
November 14, 2019

Search:

Recent Posts

Anavex Life Sciences Issued New U.S. Patent for ANAVEX®2-73 Treatment of Neurodevelopmental Disorders including Rett Syndrome and Multiple Sclerosis
Anavex Life Sciences Reports Fiscal Year 2019 Financial Results And Provides Clinical Study Updates
Anavex Life Sciences to Announce Fiscal 2019 Year End Financial Results on Monday December 16, 2019

Recent Comments

Archives

ANAVEX® is a trademark of Anavex®Life Sciences Corp. - 2019 All Rights Reserved